<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03726554</url>
  </required_header>
  <id_info>
    <org_study_id>CMG2017-70E</org_study_id>
    <nct_id>NCT03726554</nct_id>
  </id_info>
  <brief_title>Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty</brief_title>
  <official_title>Comprehensive Reverse Shoulder: Porous Augmented Glenoid Baseplate and Mini Humeral Tray Post-Market Clinical Follow-up Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zimmer Biomet</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zimmer Biomet</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is a multicenter, prospective, non-randomized, non-controlled, dual cohort post&#xD;
      market surveillance study. The primary objective of this study is to confirm the safety and&#xD;
      performance of the Comprehensive Reverse Shoulder System when used with the Comprehensive&#xD;
      Porous Augmented Glenoid Baseplate and/or Comprehensive Mini Humeral Tray in primary and&#xD;
      revision reverse shoulder arthroplasty.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Comprehensive Reverse Porous Augmented Glenoid Baseplate and Comprehensive Mini Humeral&#xD;
      Tray belong to the Comprehensive Reverse Shoulder Arthroplasty System. They were developed to&#xD;
      provide patients with grossly deficient rotator cuffs with another surgical option. The aim&#xD;
      of the Comprehensive Reverse Shoulder System is to increase shoulder function while reducing&#xD;
      pain.&#xD;
&#xD;
      A maximum of 7 sites will contribute to this study. Enrollment of 7 sites on a global scale&#xD;
      will allow for assessment of device consistency across different regions. Enrollment per site&#xD;
      will not exceed 45 shoulders. 146 implants will be included in this study with competitive&#xD;
      enrollment. All potential study subjects will be required to participate in the Informed&#xD;
      Consent process.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 28, 2018</start_date>
  <completion_date type="Anticipated">February 2030</completion_date>
  <primary_completion_date type="Anticipated">February 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Implant Survivorship</measure>
    <time_frame>10 years</time_frame>
    <description>Based on removal or intended removal of the device and determined using the Kaplan-Meier method</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Frequency and Incidence of Adverse Events</measure>
    <time_frame>10 years</time_frame>
    <description>Monitoring the frequency and incidence of adverse events, serious adverse events, adverse device effects, serious adverse device effects, and unanticipated serious adverse device effects as well as device deficiencies.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical efficacy of the device is assessed using the American Shoulder and Elbow Surgeon Score Patient Questionnaire.</measure>
    <time_frame>10 years</time_frame>
    <description>Pain, function, and activities of daily living are measured. The American Shoulder and Elbow Surgeon (ASES) scale is 0-100. 100 is the highest score and indicates the greatest function while 0 is the lowest score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiographic Performance</measure>
    <time_frame>10 years</time_frame>
    <description>X-rays will be evaluated for radiolucency, osteolysis, atrophy, hypertrophy, osteophytes, component migration, scapular notching and heterotopic ossification</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">102</enrollment>
  <condition>Arthropathy of Shoulder Region</condition>
  <condition>Grossly Deficient Rotator Cuff</condition>
  <condition>Osteoarthritis of the Shoulder</condition>
  <condition>Rheumatoid Arthritis Without Humeral Metaphyseal Defects</condition>
  <condition>Post-Traumatic Arthritis</condition>
  <arm_group>
    <arm_group_label>Comp. Rev. Porous Augmented Glenoid</arm_group_label>
    <description>Subjects with a grossly deficient rotator cuff in need of a reverse shoulder arthroplasty who met the inclusion/exclusion criteria and received the Comprehensive Reverse Porous Augmented Glenoid.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Comp. Rev. Mini Humeral Tray</arm_group_label>
    <description>Subjects with a grossly deficient rotator cuff in need of a reverse shoulder arthroplasty who met the inclusion/exclusion criteria and received the Comprehensive Reverse Mini Humeral Tray</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comprehensive Reverse Porous Augmented Glenoid</intervention_name>
    <description>Three glenoid baseplate options designed for various severities of glenoid erosion and deformity, the device promotes bony ingrowth while restoring natural human anatomy.</description>
    <arm_group_label>Comp. Rev. Porous Augmented Glenoid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Comprehensive Mini Humeral Tray</intervention_name>
    <description>The mini humeral tray offers additional sizing options to the Comprehensive Shoulder line. The mini tray is designed to fit smaller anatomies.</description>
    <arm_group_label>Comp. Rev. Mini Humeral Tray</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients in need of a reverse shoulder arthroplasty who receive a Comprehensive Reverse&#xD;
        Porous Augmented Glenoid and/or Comprehensive Mini Humeral Tray who meet all of the&#xD;
        inclusion and none of the exclusion criteria.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient must be 18 years of age or older.&#xD;
&#xD;
          -  Patient must be anatomically and structurally suited to receive the implants and&#xD;
             possess a functional deltoid.&#xD;
&#xD;
          -  Patient must have a grossly deficient rotator cuff with severe arthropathy and/or a&#xD;
             previously failed shoulder joint replacement with a grossly deficient rotator cuff.&#xD;
&#xD;
          -  Patient must be able and willing to complete the protocol required follow-up.&#xD;
&#xD;
          -  Patient must be able and willing to sign the Institutional Review Board/Ethics&#xD;
             Committee approved informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient is a prisoner.&#xD;
&#xD;
          -  Patient is a current alcohol or drug abuser.&#xD;
&#xD;
          -  Uncooperative patient or patient with neurologic disorders who is incapable or&#xD;
             unwilling to follow directions.&#xD;
&#xD;
          -  Patient presents with osteoporosis.&#xD;
&#xD;
          -  Patient has a metabolic disorder that may impair bone formation.&#xD;
&#xD;
          -  Patient has osteomalacia.&#xD;
&#xD;
          -  Patient has distant foci of infections which may spread to the implant site.&#xD;
&#xD;
          -  Patient has rapid joint destruction, marked bone loss or bone resorption apparent on&#xD;
             roentgenogram.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kacy Arnold, RN, MBA</last_name>
    <role>Study Director</role>
    <affiliation>Zimmer Biomet</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Andrews Research and Education Foundation</name>
      <address>
        <city>Gulf Breeze</city>
        <state>Florida</state>
        <zip>32561</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Orthopedic Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40241</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48073</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Research Foundation for the State University of New York</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Campbell Foundation</name>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Rector and Visitors of the University of Virginia</name>
      <address>
        <city>Charlottesville</city>
        <state>Virginia</state>
        <zip>22903</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 26, 2018</study_first_submitted>
  <study_first_submitted_qc>October 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>September 7, 2021</last_update_submitted>
  <last_update_submitted_qc>September 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Reverse Shoulder Arthroplasty</keyword>
  <keyword>Medical Device</keyword>
  <keyword>Performance</keyword>
  <keyword>Safety</keyword>
  <keyword>Shoulder Prosthesis</keyword>
  <keyword>Glenoid Erosion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

